N. A. Rodriguez-Jimenez

发表

Performance of Risk Indices for Identifying Low Bone Mineral Density and Osteoporosis in Mexican Mestizo Women with Rheumatoid Arthritis

M. Suarez‐Almazor, L. Gonzalez-Lopez, J. Morales-Romero, 2012, Journal of Rheumatology.

Myostatin Levels and the Risk of Myopenia and Rheumatoid Cachexia in Women with Rheumatoid Arthritis

L. Gonzalez-Lopez, C. Cabrera-Pivaral, J. Gámez-Nava, 2022, Journal of immunology research.

Utility of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as biomarker to predict therapeutic response to methotrexate in rheumatoid arthritis

L. Gonzalez-Lopez, J. Gámez-Nava, M. L. Vazquez-Villegas, 2017, Innate immunity.

Modifications in Lipid Levels Are Independent of Serum TNF-α in Rheumatoid Arthritis: Results of an Observational 24-Week Cohort Study Comparing Patients Receiving Etanercept Plus Methotrexate or Methotrexate as Monotherapy

L. Gonzalez-Lopez, J. Gámez-Nava, A. Rocha-Muñoz, 2014, BioMed research international.

Association of adipokines, interleukin-6, and tumor necrosis factor-α concentrations with clinical characteristics and presence of spinal syndesmophytes in patients with ankylosing spondylitis: A cross-sectional study

J. Muñóz-Valle, L. Gonzalez-Lopez, J. Gámez-Nava, 2017, The Journal of international medical research.

Serum Neuropeptide Y Levels Are Associated with TNF-α Levels and Disease Activity in Rheumatoid Arthritis

L. Gonzalez-Lopez, J. Gámez-Nava, M. Salazar-Páramo, 2020, Journal of immunology research.

Therapeutic response to leflunomide in combo therapy and monotherapy is associated to serum teriflunomide (A77 1726) levels

R. I. López-Roa, J. Muñóz-Valle, S. Cerpa-Cruz, 2022, Scientific Reports.

Serum levels of adiponectin and leptin as biomarkers of proteinuria in lupus nephritis

L. Gonzalez-Lopez, J. Gámez-Nava, M. L. Vazquez-Villegas, 2017, PloS one.

Anti-nucleosome antibodies increase the risk of renal relapse in a prospective cohort of patients with clinically inactive systemic lupus erythematosus

J. Muñóz-Valle, L. Gonzalez-Lopez, J. Gámez-Nava, 2020, Scientific Reports.

Influence of Anti-TNF and Disease Modifying Antirheumatic Drugs Therapy on Pulmonary Forced Vital Capacity Associated to Ankylosing Spondylitis: A 2-Year Follow-Up Observational Study

L. Gonzalez-Lopez, J. Gámez-Nava, A. Rocha-Muñoz, 2015, Journal of immunology research.

Genotypic Analyses of the Sclerostin rs851056 and Dickkopf rs1569198 Polymorphisms in Mexican-Mestizo Postmenopausal Osteoporosis: A Case-Control Study.

L. Gonzalez-Lopez, M. L. Vazquez-Villegas, A. Nava-Zavala, 2021, Genetic testing and molecular biomarkers.

Risk Factors Associated with Adverse Events Leading to Methotrexate Withdrawal in Elderly Rheumatoid Arthritis Patients: A Retrospective Cohort Study

L. Gonzalez-Lopez, J. Gámez-Nava, E. Cardona-Muñoz, 2024, Journal of clinical medicine.

Effects of Renin–Angiotensin System Inhibitors on Atrial Mechanics Parameters in Patients with Metabolic Syndrome

L. Gonzalez-Lopez, J. Gámez-Nava, E. Cardona-Muñoz, 2023, Journal of cardiovascular pharmacology and therapeutics.

Role of Myostatin in Rheumatoid Arthritis: A Review of the Clinical Impact

E. Cardona-Muñoz, S. Totsuka-Sutto, M. Ramirez-Villafaña, 2024, Diagnostics.

Syndecan-1 Levels in Females with Active Rheumatoid Arthritis

L. Gonzalez-Lopez, J. Gámez-Nava, E. Olivas-Flores, 2024, Journal of clinical medicine.

Complementary Therapies and Their Association with Problems in Therapeutic Adherence to Conventional Synthetic DMARDs in Rheumatoid Arthritis: A Cross-Sectional Study

S. Cerpa-Cruz, L. Gonzalez-Lopez, J. Gámez-Nava, 2023, Healthcare.